Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019).
Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, Kunte C, Muir T, Brizio M, Sersa G, Pritchard Jones R, Moir G, Orlando A, Banerjee SM, Kis E, McCaul JA, Grischke EM, Matteucci P, Mowatt D, Bechara FG, Mascherini M, Lico V, Giorgione R, Seccia V, Schepler H, Pecorari G, MacKenzie Ross AD, Bisase B, Gehl J. Clover AJP, et al. Among authors: bechara fg. Eur J Cancer. 2020 Oct;138:30-40. doi: 10.1016/j.ejca.2020.06.020. Epub 2020 Aug 21. Eur J Cancer. 2020. PMID: 32836172
Electrochemotherapy for the treatment of cutaneous squamous cell carcinoma: The INSPECT experience (2008-2020).
Bertino G, Groselj A, Campana LG, Kunte C, Schepler H, Gehl J, Muir T, Clover JAP, Quaglino P, Kis E, Mascherini M, Bisase B, Pecorari G, Bechara F, Matteucci P, Odili J, Russano F, Orlando A, Pritchard-Jones R, Moir G, Mowatt D, Silvestri B, Seccia V, Saxinger W, de Terlizzi F, Sersa G. Bertino G, et al. Front Oncol. 2022 Sep 20;12:951662. doi: 10.3389/fonc.2022.951662. eCollection 2022. Front Oncol. 2022. PMID: 36203425 Free PMC article.
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma.
Campana LG, Farronato S, Hodgetts J, Odili J, Vecchiato A, Bracken A, Baier S, Bechara FG, Borgognoni L, Caracò C, Carvalhal S, Covarelli P, Clover J, Eisendle K, Fantini F, Fierro MT, Farricha V, Gregorelli C, Hafner J, Kunte C, Gerlini G, Hessam S, Mandalà M, Piazzalunga D, Quaglino P, Snoj M, Ross AM, Trigona B, Moreno-Ramirez D, Tauceri F, Peach H, Rutkowski P, Muir T, de Terlizzi F, Patuzzo R, Mühlstädt M, Dietrich KA, Mussack T, Matteucci P, Kis E, Ascierto P, Sersa G, Valpione S; Melanoma Delphi Working Group. Campana LG, et al. Among authors: bechara fg. Br J Surg. 2023 Jun 12;110(7):818-830. doi: 10.1093/bjs/znad105. Br J Surg. 2023. PMID: 37131298
A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trial.
Schultheis M, Staubach P, Nikolakis G, Schollenberger L, Mauch M, Burckhardt M, Heise M, Zamsheva M, Strobel A, Langer G, Bechara F, Kirschner U, Hennig K, Kunte C, Goebeler M, Grabbe S. Schultheis M, et al. Br J Dermatol. 2023 Jul 17;189(2):170-179. doi: 10.1093/bjd/ljad135. Br J Dermatol. 2023. PMID: 37132470 Clinical Trial.
A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effectiveness.
Heise M, Staubach P, Nikolakis G, Schollenberger L, Mauch M, Burckhardt M, Zamsheva M, Strobel A, Langer G, Bechara F, Kirschner U, Hennig K, Kunte C, Goebeler M, Podda M, Grabbe S, Schultheis M. Heise M, et al. J Dermatolog Treat. 2023 Dec;34(1):2284105. doi: 10.1080/09546634.2023.2284105. Epub 2023 Nov 27. J Dermatolog Treat. 2023. PMID: 38010850 Free article. Clinical Trial.
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment.
Zouboulis CC, Bechara FG, Benhadou F, Bettoli V, Bukvić Mokos Z, Del Marmol V, Dolenc-Voljč M, Giamarellos-Bourboulis EJ, Grimstad Ø, Guillem P, Horváth B, Hunger RE, Ingram JR, Ioannidis D, Just E, Kemény L, Kirby B, Liakou AI, McGrath BM, Marzano AV, Matusiak Ł, Molina-Leyva A, Nassif A, Podda M, Prens EP, Prignano F, Raynal H, Romanelli M, Saunte DML, Szegedi A, Szepietowski JC, Tzellos T, Valiukevičienė S, van der Zee HH, van Straalen KR, Villumsen B, Jemec GBE. Zouboulis CC, et al. Among authors: bechara fg. J Eur Acad Dermatol Venereol. 2024 Dec 19. doi: 10.1111/jdv.20472. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39699926
Upadacitinib treatment associated with varicella zoster infection complicated by haemophagocytic lymphohistiocytosis in a patient with severe hidradenitis suppurativa.
Abu Rached N, Gambichler T, Ocker L, Schultheis B, Susok L, Schmidt W, Bechara FG. Abu Rached N, et al. Among authors: bechara fg. J Eur Acad Dermatol Venereol. 2024 Feb;38(2):e139-e141. doi: 10.1111/jdv.19483. Epub 2023 Sep 13. J Eur Acad Dermatol Venereol. 2024. PMID: 37641970 No abstract available.
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.
Mastacouris N, Tannenbaum R, Strunk A, Koptyev J, Aarts P, Alhusayen R, Bechara FG, Benhadou F, Bettoli V, Brassard A, Brown D, Choon SE, Coutts P, da Silva DLF, Daveluy S, Dellavalle RP, Del Marmol V, Emtestam L, Gebauer K, George R, Giamarellos-Bourboulis EJ, Goldfarb N, Hamzavi I, Hazen PG, Horváth B, Hsiao J, Ingram JR, Jemec GBE, Kirby JS, Lowes MA, Marzano AV, Matusiak L, Naik HB, Okun MM, Oon HH, Orenstein LAV, Paek SY, Pascual JC, Fernandez-Peñas P, Resnik BI, Sayed CJ, Thorlacius L, van der Zee HH, van Straalen KR, Garg A. Mastacouris N, et al. Among authors: bechara fg. JAMA Dermatol. 2023 Nov 1;159(11):1258-1266. doi: 10.1001/jamadermatol.2023.3282. JAMA Dermatol. 2023. PMID: 37755725
268 results